Rhesus monkey model for fetal gene transfer: Studies with retroviral-based vector systems

Molecular Therapy

Volumn 3, Issue 2, 2001, Pages 128-138

  Tarantal, Alice F ^a,b   O'Rourke, John P ^c   Case, Scott S ^d   Newbound, Garret C ^c   Li, Jun ^a   Lee, Chang I ^a   Baskin, Carole R ^c   Kohn, Donald B ^d   Bunnell, Bruce A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

EGFP; Fetal gene transfer; HIV 1 derived lentivirus; MLV; Rhesus monkey

Indexed keywords

DNA; ENVELOPE PROTEIN; GREEN FLUORESCENT PROTEIN; KANAMYCIN KINASE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BONE MARROW; BRAIN CORTEX; CELL SUSPENSION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS; GENE THERAPY; GENE TRANSFER; GESTATIONAL AGE; HEMATOPOIETIC STEM CELL; HISTOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LIVER; LYMPH NODE; MALE; MOLONEY LEUKEMIA ONCOVIRUS; MONONUCLEAR CELL; NEWBORN; NONHUMAN; PATIENT MONITORING; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PRIMATE; PROMOTER REGION; REPORTER GENE; RETROVIRUS; RHESUS MONKEY; SPLEEN; SUPERNATANT; THYMUS; TRANSGENE; ULTRASOUND; VESICULAR STOMATITIS VIRUS;

ANIMALIA; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MACACA MULATTA; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE; PRIMATES; UNIDENTIFIED RETROVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0034985713     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0255     Document Type: Article

References (64)

1. Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): Comparison of enzymatic and metabolite analysis
2. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood
3. First-trimester biochemical and molecular diagnoses using chorionic villi: High accuracy in the U.S. collaborative study
4. Genetic diagnosis in the first trimester: The norm for the 1990s
5. Krabbe's disease: First trimester diagnosis confirmed on cultured amniotic fluid cells and fetal tissues
6. Prenatal diagnosis of lysosomal storage diseases
7. The ethical challenges of in utero gene therapy
8. Fetal somatic gene therapy
9. Prenatal gene therapy: Can the technical hurdles be overcome?
10. Prospects for in utero human gene therapy
11. Status of gene therapy for cystic fibrosis lung disease
12. Strategies for targeting therapeutic gene delivery
13. Gene therapy - A loss of innocence
14. Latest developments in gene transfer technology: Achievements, perspectives, and controversies over therapeutic applications
15. - human hematopoietic cells by HIV-1-based lentiviral vectors
16. Lentiviruses as gene transfer agents for delivery to non-dividing cells
17. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
18. Use of ultrasound for early pregnancy detection in the rhesus and cynomolgus macaque (Macaca mulatta and Macaca fascicularis)
19. Characterization of the insulin-like growth factor (IGF) axis in the serum of maternal and fetal macaques (Macaca mulatta and Macaca fascicularis)
20. Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells
21. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells
22. High-titer packaging cells producing recombinant retroviruses resistant to human serum
23. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses
24. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
25. A transient three-plasmid expression system for the production of high titer retroviral vectors
26. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: Comparison of VSV-G and amphotropic gene transfer
27. Multiple attenuated lentiviral vector achieves efficient gene delivery in vivo
28. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
29. Interventional ultrasound in pregnant macaques: Embryonic/fetal applications
30. Prenatal growth in the cynomolgus and rhesus macaque (Macaca fascicularis and Macaca mulatta): A comparison by ultrasonography
31. Hematologic reference values for the fetal long-tailed macaque (Macaca fascicularis)
32. Evaluation of the bioeffects of prenatal ultrasound exposure in the cynomolgus macaque (Macaca fascicularis). I. Neonatal/Infant observations
33. Transplantation of human peripheral blood stem cells (PBSC) into fetal rhesus monkeys (Macaca mulatta)
34. Effects of viral virulence on intrauterine growth in SIV-infected fetal rhesus macaques (Macaca mulatta)
35. Pre- and postnatal treatment of the rhesus macaque (Macaca mulatta) with azidothymidine (AZT). I. Fetal studies
36. Effects of SIV infection on fetal development and pregnancy outcome in the rhesus macaque (Macaca mulatta)
37. Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys
38. Administration of recombinant human stem cell factor (rhSCF) and granulocyte-colony stimulating factor (rhG-CSF) to maternal and fetal rhesus monkeys (Macaca mulatta)
39. Genetic treatment of severe hemoglobinopathies: The combat against transgene variegation and transgene silencing
40. Fetal cells from maternal blood: Purpose, biological questions, technical challenges
41. The gross pathology of the rhesus monkey placenta
42. Ultrasonographically guided direct gene transfer in utero: Successful induction of betagalactosidase in a rabbit model
43. Fetal liver hematopoietic stem cells as a target for in utero retroviral gene transfer
44. Myeloproliferative sarcoma virus directed expression of β-galactosidase following retroviral transduction of murine hematopoietic cells
45. Adenovirus-mediated gene transfer to the peritoneum and hepatic parenchyma of fetal mice in utero
46. Adenovirus-mediated gene transfer in the midgestation fetal mouse
47. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero
48. r gene in sheep after direct injection of retroviral vectors into preimmune fetuses
49. Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer
50. Adenovirus-mediated in utero gene transfer in mice and guinea pigs: Tissue distribution of recombinant adenovirus determined by quantitative Taqman-polymerase chain reaction assay
51. Successful expression of β-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein
52. In utero transfer and expression of exogenous genes in sheep
53. Intrauterine gene transfer: Gestational stage-specific gene delivery in mice
54. Gene silencing as a threat to the success of gene therapy
55. Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine
56. Amelioration of retroviral vector silencing in locus control region β-globin-transgenic mice and transduced F9 embryonic cells
57. Targeted remodeling of human β-globin promoter chromatin structure produces increased expression and decreased silencing
58. Human fetal gene therapy
59. Germline alteration by gene therapy: Assessing and reducing the risks
60. Gene Therapy Advisory Committee (GTAC) Report on the Potential Use of Gene Therapy in Utero
61. Comparison of embryonic and foetal development in man and rhesus monkey
62. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences